ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaAtopia Therapeutics SA
Atopia Therapeutics SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Atopia Therapeutics SA is developing a disease‑modifying therapy for asthma and other allergic diseases. Its lead candidate, ATP‑R13, is a patented recombinant protein derived from a Helicobacter pylori molecule intended for oral administration to modulate immune tolerance and reduce inflammation; the company holds an exclusive worldwide licence from the University of Zurich and is conducting IND‑enabling activities.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
Development of a disease-modifying therapy for asthma and allergic diseases
Development of a first-in-class, disease-modifying therapy for asthma and other allergic diseases based on a molecule from Helicobacter pylori.
Development of ATP-R13
Development of the patented, optimized recombinant protein version ATP-R13 as an orally administered immunomodulatory active ingredient to reduce inflammation and allergy symptoms.
Partnerships for clinical and preclinical development
Collaboration with industrial and financial partners for the next development phases, including use of internal expertise and the network of specialists and CROs.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Atopia Therapeutics SA

Trust & reputation

ranQ Trust Score of Atopia Therapeutics SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Atopia Therapeutics SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Atopia Therapeutics SA scores 79.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.86.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Atopia Therapeutics SA scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Atopia Therapeutics SA scores 12.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.12.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Atopia Therapeutics SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Atopia Therapeutics SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Atopia Therapeutics SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Atopia Therapeutics SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Atopia Therapeutics SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Chemin des Mines 15
1202 Geneva

At a glance

Legal form
Corporation
UID
CHE-346.109.235
Founded
2016 · 10 years
Last commercial register change
January 27, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SS
    STALICLA SA
    Geneva
    CR
    CELL RECEPTOR SA
    Geneva
    AS
    Ageronix SA
    Carouge Ge
    NS
    NovImmune SA
    Plan-Les-Ouates
    AS
    argenx Switzerland SA
    Châtelaine
    MT
    MPC Therapeutics SA
    Geneva
    IT
    IREMIS Therapeutics SA
    Anières
    AP
    Addex Pharma SA
    Plan-Les-Ouates